IRulya Therapeutics Inc. (IRLA)
NASDAQ: IRLA · Real-Time Price · USD
33.23
+3.23 (10.77%)
At close: Oct 15, 2026, 4:00 PM EDT
32.57
-0.66 (-1.99%)
After-hours: Oct 15, 2026, 7:30 PM EDT
IRulya Therapeutics Market Cap
IRulya Therapeutics has a market cap or net worth of $33.8 million as of October 15, 2026. Its market cap has decreased by 67.57% in one year.
Market Cap
33.80M
Enterprise Value
-82.18M
1-Year Change
-67.57%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since May 9, 2019, IRulya Therapeutics's market cap has decreased from $855.57M to $33.80M, a decrease of -96.05%. That is a compound annual growth rate of -35.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 33.80M | -81.88% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 33.44M |
| Aligos Therapeutics | 32.66M |
| Metagenomi Therapeutics | 32.53M |
| BriaCell Therapeutics | 31.99M |
| Actinium Pharmaceuticals | 30.64M |
| NextCure | 30.12M |
| GridAI Technologies | 30.09M |
| CEL-SCI | 30.08M |